Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011–2013

Details

• Journal Article:
  Preventing Chronic Disease (PCD)
• Personal Author:
  Berman, Rachel Stein ; Smock, Laura ; Bair-Merritt, Megan H. ; Cochran, Jennifer ; Geltman, Paul L.
• Description:
  Introduction ; The receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses. ; Methods ; We examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population. ; Results ; Forty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68% of similarly aged refugees. Males (adjusted odds ratio aOR, 0.62; 95% confidence interval CI, 0.52–0.74), refugees older than 13 years (aOR, 0.74; 95% CI, 0.60–0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95% CI, 0.59–0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95% CI, 1.3–1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95% CI, 0.37–0.63) than older refugees. ; Conclusion ; Specialized post-arrival health assessment may improve refugees’ immunization rates.
• Subjects:
  • Adolescent
  • Child
  • Female
  • Hepatitis B/prevention & control
  • Hepatitis B virus
  • Humans
  • Immunization
  • Male
  • Papillomavirus Infections/prevention & control
  • Papillomavirus Vaccines
  More +
• Source:
  Prev Chronic Dis. 14.
• DOI:
  http://dx.doi.org/10.5888/pcd14.160442
• ISSN:
  1545-1151
• Pubmed ID:
  28641071
• Pubmed Central ID:
  PMC5484014
• Document Type:
  Journal Article
• Funding:
  U50 CK000297/CK/NCEZID CDC HHS/United States
• Place as Subject:
  Massachusetts
• Volume:
  14
• Download URL:
  https://stacks.cdc.gov/view/cdc/46732/cdc_46732_DS1.pdf
• File Type:
  [PDF - 285.44 KB]
• Collection(s):
  Preventing Chronic Disease
• Main Document Checksum:
  urn:sha-512:606cd3a3aa60f569b6a4ecbf227c0e20a1be7abf73f0726e7250b773d867cba95143a79ab40ba92c12781c91ada48a271a241bd523ebd0862fe9981fc1961ba5